Search by Drug Name or NDC

    NDC 00713-0804-31 TAZAROTENE 1 mg/g Details

    TAZAROTENE 1 mg/g

    TAZAROTENE is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is TAZAROTENE.

    Product Information

    NDC 00713-0804
    Product ID 0713-0804_0b4b0b29-a411-44a4-e063-6294a90ab3ba
    Associated GPIs
    GCN Sequence Number 031601
    GCN Sequence Number Description tazarotene GEL (GRAM) 0.1 % TOPICAL
    HIC3 L5F
    HIC3 Description ANTIPSORIATICS AGENTS
    GCN 29222
    HICL Sequence Number 013315
    HICL Sequence Number Description TAZAROTENE
    Brand/Generic Generic
    Proprietary Name TAZAROTENE
    Proprietary Name Suffix n/a
    Non-Proprietary Name tazarotene
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form GEL
    Route TOPICAL
    Active Ingredient Strength 1
    Active Ingredient Units mg/g
    Substance Name TAZAROTENE
    Labeler Name Cosette Pharmaceuticals, Inc.
    Pharmaceutical Class Retinoid [EPC], Retinoids [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA214136
    Listing Certified Through 2024-12-31

    Package

    NDC 00713-0804-31 (00713080431)

    NDC Package Code 0713-0804-31
    Billing NDC 00713080431
    Package 1 TUBE in 1 CARTON (0713-0804-31) / 30 g in 1 TUBE
    Marketing Start Date 2022-09-14
    NDC Exclude Flag N
    Pricing Information N/A